On October 14, 2026, Medline Inc. initiated a voluntary field action involving the removal and discontinuation of all Medline Brand beds, including homecare, bariatric, and long-term care models, along with associated accessories and parts. The company estimates costs up to $220 million for inventory impairment, disposal, and customer credits, expected in 2026 and 2027. Affected products generated approximately $60 million in net sales over the trailing twelve months ended June 27, 2026. Medline does not expect a material impact on fiscal year 2026 results or full-year guidance. The company operates in the healthcare supply and medical equipment industry.
